The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Aptamer therapeutics advance
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase
Cerchia, L., Ducongé, F., Pestourie, C., Boulay, J., Aissouni, Y., Gombert, K., Tavitian, B., de Franciscis, V., & Libri, D. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030123 · Cited by 246
RetractedTuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
In vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812
Self-citationGhrelin induces adiposity in rodents
Tschöp, M., Smiley, D. L., & Heiman, M. L. (2000) · Nature · doi:10.1038/35038090 · Cited by 3,949
Selection of single-stranded DNA molecules that bind and inhibit human thrombin
Bock, L. C., Griffin, L. C., Latham, J. A., Vermaas, E. H., & Toole, J. J. (1992) · Nature · doi:10.1038/355564a0 · Cited by 2,469
The discovery of receptor tyrosine kinases: targets for cancer therapy
Gschwind, A., Fischer, O. M., & Ullrich, A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1360 · Cited by 1,227
Aptamers: An Emerging Class of Therapeutics
Nimjee, S. M., Rusconi, C. P., & Sullenger, B. A. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.062904.144915 · Cited by 937
Nanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
RNA aptamers as reversible antagonists of coagulation factor IXa
Rusconi, C. P., Scardino, E., Layzer, J., Pitoc, G. A., Ortel, T. L., Monroe, D., & Sullenger, B. A. (2002) · Nature · doi:10.1038/nature00963 · Cited by 512
In Vitro Evolution of Functional DNA Using Capillary Electrophoresis
Mendonsa, S. D., & Bowser, M. T. (2004) · Journal of the American Chemical Society · doi:10.1021/ja037832s · Cited by 417
RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase.
Tuerk, C., MacDougal, S., & Gold, L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6988 · Cited by 415
Mirror-image RNA that binds D-adenosine
Klußmann, S., Nolte, A., Bald, R., Erdmann, V. A., & Fürste, J. P. (1996) · Nature Biotechnology · doi:10.1038/nbt0996-1112 · Cited by 399
Labrijn, A. F., Poignard, P., Raja, A., Zwick, M. B., Delgado, K., Franti, M., Binley, J., Vivona, V., Grundner, C., Huang, C.-C., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10557-10565.2003 · Cited by 357
Direct In Vitro Selection of a 2′-O-Methyl Aptamer to VEGF
Burmeister, P. E., Lewis, S. D., Silva, R. F., Preiss, J. R., Horwitz, L. R., Pendergrast, P. S., McCauley, T. G., Kurz, J. C., Epstein, D. M., Wilson, C., et al. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.10.017 · Cited by 347
Antidote-mediated control of an anticoagulant aptamer in vivo
Rusconi, C. P., Roberts, J. D., Pitoc, G. A., Nimjee, S. M., White, R. R., Quick, G., Scardino, E., Fay, W. P., & Sullenger, B. A. (2004) · Nature Biotechnology · doi:10.1038/nbt1023 · Cited by 339
Berezovski, M., Drabovich, A., Krylova, S. M., Musheev, M., Okhonin, V., Petrov, A., & Krylov, S. N. (2005) · Journal of the American Chemical Society · doi:10.1021/ja042394q · Cited by 298
Pharmacokinetics and Biodistribution of Novel Aptamer Compositions
Healy, J. M., Lewis, S. D., Kurz, M., Boomer, R. M., Thompson, K. M., Wilson, C., & McCauley, T. G. (2004) · Pharmaceutical Research · doi:10.1007/s11095-004-7676-4 · Cited by 298
Application of locked nucleic acids to improve aptamer in vivo stability and targeting function
Schmidt, K. S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh862 · Cited by 287
Aptamers—basic research, drug development, and clinical applications
Proske, D., Blank, M., Buhmann, R., & Resch, A. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0193-5 · Cited by 281
Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival.
Petitclerc, É., Strömblad, S., Schalscha, T. V., Mitjans, F., Piulats, J., Montgomery, A. M. P., Cheresh, D. A., & Brooks, P. C. (1999) · PubMed · Cited by 279
Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration
Ng, E. W. M., & Adamis, A. P. (2005) · Canadian Journal of Ophthalmology · doi:10.1016/s0008-4182(05)80078-x · Cited by 273
Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis
Hansford, J. R., & Mulligan, L. M. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.11.817 · Cited by 241
Capillary Electrophoresis-SELEX Selection of Aptamers with Affinity for HIV-1 Reverse Transcriptase
Mosing, R. K., Mendonsa, S. D., & Bowser, M. T. (2005) · Analytical Chemistry · doi:10.1021/ac050836q · Cited by 232
Mirror-design of L-oligonucleotide ligands binding to L-arginine
Nolte, A., Klußmann, S., Bald, R., Erdmann, V. A., & Fürste, J. P. (1996) · Nature Biotechnology · doi:10.1038/nbt0996-1116 · Cited by 206
Ichihara, M. (2004) · Cancer Letters · doi:10.1016/s0304-3835(03)00456-7 · Cited by 197
Combinatorial selection of high affinity RNA ligands to live African trypanosomes
Homann, M., & Goringer, H. U. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.9.2006 · Cited by 190
Rhie, A., Kirby, L., Sayer, N., Wellesley, R., Disterer, P., Sylvester, I., Gill, A., Hope, J., James, W., & Tahiri-Alaoui, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305297200 · Cited by 185
Spiegelmers: Biostable Aptamers
Eulberg, D., & Klussmann, S. (2003) · ChemBioChem · doi:10.1002/cbic.200300663 · Cited by 181
Tucker, C. E., Chen, L.-S., Judkins, M. B., Farmer, J. A., Gill, S. C., & Drolet, D. W. (1999) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(99)00285-6 · Cited by 176
Microfluidic System for Studying the Interaction of Nanoparticles and Microparticles with Cells
Farokhzad, O. C., Khademhosseini, A., Jon, S., Hermmann, A., Cheng, J., Chin, C., Kiselyuk, A., Teply, B., Eng, G., & Langer, R. (2005) · Analytical Chemistry · doi:10.1021/ac050312q · Cited by 174
Jeon, S. H., Kayhan, B., Ben-Yedidia, T., & Arnon, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409059200 · Cited by 169
Evolution of a T7 RNA polymerase variant that transcribes 2′-O-methyl RNA
Chelliserrykattil, J., & Ellington, A. D. (2004) · Nature Biotechnology · doi:10.1038/nbt1001 · Cited by 168
Self-citationHigh-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus
Schneider, D. J., Feigon, J., Hostomsky, Z., & Gold, L. (1995) · Biochemistry · doi:10.1021/bi00029a037 · Cited by 165
Ghrelin Neutralization by a Ribonucleic Acid-SPM Ameliorates Obesity in Diet-Induced Obese Mice
Shearman, L. P., Wang, S.-P., Helmling, S., Stribling, D. S., Mazur, P., Ge, L., Wang, L., Klußmann, S., MacIntyre, D. E., Howard, A. D., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0993 · Cited by 158
de Smidt, P. C., Doan, T. L., Falco, S. D., et al. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.17.4695 · Cited by 155
Padilla, R. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/gnf138 · Cited by 142
Aptamers as tools for target validation
Blank, M., & Blind, M. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.06.011 · Cited by 128
Pegaptanib: In Exudative Age-Related Macular Degeneration
Siddiqui, M. A. A., & Keating, G. M. (2005) · Drugs · doi:10.2165/00003495-200565110-00010 · Cited by 110
The potential of aptamers as anticoagulants
Nimjee, S. M., Rusconi, C. P., Harrington, R. A., & Sullenger, B. A. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.01.002 · Cited by 109
Burke, D. H., Scates, L., Andrews, K., & Gold, L. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0667 · Cited by 99
Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass
DeAnda, A., Coutre, S. E., Moon, M. R., Vial, C. M., Griffin, L. C., Law, V. S., Komeda, M., Leung, L. L. K., & Miller, D. C. (1994) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(94)92206-3 · Cited by 95
Encapsulating Streptomycin within a Small 40-mer RNA
Tereshko, V. A., Skripkin, E. A., & Patel, D. J. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00024-3 · Cited by 87
Watson, S. R., Chang, Y.-F., O'Connell, D., WEIGAND, L., Ringquist, S., & Parma, D. H. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.63 · Cited by 79
Sialyllactose-binding modified DNA aptamer bearing additional functionality by SELEX
Masud, M. M., Kuwahara, M., Ozaki, H., & Sawai, H. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.12.009 · Cited by 78
Mi, J., Zhang, X., Giangrande, P. H., McNamara, J. O., Nimjee, S. M., Sarraf‐Yazdi, S., Sullenger, B. A., & Clary, B. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.043 · Cited by 74
Protective effects of an aptamer inhibitor of neutrophil elastase in lung inflammatory injury
Bless, N. M., Smith, D., Charlton, J., Czermak, B. J., Schmal, H., Friedl, H. P., & Ward, P. A. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00376-9 · Cited by 70
Discriminatory aptamer reveals serum response element transcription regulated by cytohesin-2
Theis, M., Knorre, A., Kellersch, B., Moelleken, J., Wieland, F., Kolanus, W., & Famulok, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402901101 · Cited by 62
Somasunderam, A., Ferguson, M. R., Rojo, D. R., Thiviyanathan, V., Li, X., O’Brien, W. A., & Gorenstein, D. G. (2005) · Biochemistry · doi:10.1021/bi0507074 · Cited by 52
Use of minimally modified antisense oligonucleotides for specific inhibition of gene expression
Uhlmann, E., Peyman, A., Ryte, A. S., Schmidt, A., & Buddecke, E. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)13017-4 · Cited by 48
Aptamers: prospects in therapeutics and biomedicine
Amy, C. (2005) · Frontiers in bioscience · doi:10.2741/1663 · Cited by 47
Deconvolution of a Complex Target Using DNA Aptamers
Fitter, S., & James, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504772200 · Cited by 47
Aptamers containing thymidine 3′-O-phosphorodithioates: Synthesis and binding to nuclear factor-κB
Yang, X., Fennewald, S. M., Luxon, B. A., Aronson, J. F., Herzog, N. K., & Gorenstein, D. G. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00600-9 · Cited by 46
Identification of Potent and Selective RNA Antagonists of the IFN-γ-Inducible CXCL10 Chemokine
Marro, M. L., Daniels, D. A., McNamee, A., Andrew, D. P., Chapman, T. D., Jiang, M. S., Wu, Z., Smith, J. L., Patel, K., & Gearing, K. L. (2005) · Biochemistry · doi:10.1021/bi048145w · Cited by 28
Fisher, T. S., Darden, T., & Prasad, V. R. (2003) · Journal of Virology · doi:10.1128/jvi.77.10.5837-5845.2003 · Cited by 22
Fisher, T. S., Joshi, P., & Prasad, V. R. (2005) · AIDS Research and Therapy · doi:10.1186/1742-6405-2-8 · Cited by 18
Cited by
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Keefe, A. D., Pai, S., & Ellington, A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3141 · Cited by 2,289
Self-citationFunctional Nucleic Acid Sensors
Liu, J., Cao, Z., & Lu, Y. (2009) · Chemical Reviews · doi:10.1021/cr030183i · Cited by 2,187
Erbas-Cakmak, S., Leigh, D. A., McTernan, C. T., & Nussbaumer, A. L. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00146 · Cited by 1,982
SELEX—A (r)evolutionary method to generate high-affinity nucleic acid ligands
Stoltenburg, R., Reinemann, C., & Strehlitz, B. (2007) · Biomolecular Engineering · doi:10.1016/j.bioeng.2007.06.001 · Cited by 1,430
Metadata
- Authors
- Lee, J. F., Stovall, G. M., & Ellington, A. D.
- Venue
- Current Opinion in Chemical Biology
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 10
- Issue
- 3
- Pages
- 282-289
- ISSN
- 1367-5931 (ISSN-L)
- OpenAlex
- W2131286114
- Cited by
- 398
- References
- 56
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.